SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

45,242.12 54.47
(0.12%)

Dow Jones

6,365.58 -24.27
(-0.38%)

Hang Seng

51,264.29 -621.56
(-1.20%)

Nikkei 225

10,176.45 48.49
(0.48%)

Forex

USD-INR

94.53 0.44
(0.47%)

EUR-INR

108.77 0.13
(0.12%)

GBP-INR

125.32 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nexome Capital Markets Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

508905

INE641A01013

204.1239294

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

37.01

72.11

EPS(TTM)

Face Value()

Div & Yield %

2.21

Back

Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter

Oct 31,2025

Net profit of Strides Pharma Science rose 77.52% to Rs 127.53 crore in the quarter ended September 2025 as against Rs 71.84 crore during the previous quarter ended September 2024. Sales rose 4.62% to Rs 1220.83 crore in the quarter ended September 2025 as against Rs 1166.93 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1220.83	1166.93	5
OPM %	18.88	15.76	-
PBDT	211.53	138.53	53
PBT	161.89	90.08	80
NP	127.53	71.84	78

71,947.55 -1,635.67 ( -2.22%)

45,242.12 54.47 (0.12%)

6,365.58 -24.27 (-0.38%)

51,264.29 -621.56 (-1.20%)

10,176.45 48.49 (0.48%)

94.53 0.44 (0.47%)

108.77 0.13 (0.12%)

125.32 -0.25 (-0.20%)

0.59 0.00 (-0.02%)